Drug Type ASO |
Synonyms BB 401 |
Target |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Squamous cell carcinoma of head and neck metastatic | Phase 2 | AU | 15 Mar 2018 | |
Squamous cell carcinoma of head and neck metastatic | Phase 2 | RU | 15 Mar 2018 |